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After an esophagectomy, the stomach is most commonly used to restore
continuity of the upper gastrointestinal tract. These esophago-gastric
anastomoses are prone to serious complications such as leakage associated with
high morbidity and mortality. Graft perfusion is considered to be an important
predictor for anastomotic integrity. Based on the current literature we believe
Indocyanine green fluorescence angiography (ICGA) is an easy assessment tool
for gastric tube (GT) perfusion, and it might predict anastomotic leakage (AL).
AIM
To evaluate feasibility and effectiveness of ICGA in GT perfusion assessment and
as a predictor of AL.
METHODS
This study was designed according to the PRISMA guidelines and registered in
the PROSPERO database. PubMed and EMBASE were independently searched
by 2 reviewers for studies presenting data on intraoperative ICGA GT perfusion
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assessment during esophago-gastric reconstruction after esophagectomy.
Relevant outcomes such as feasibility, complications, intraoperative surgical
changes based on ICGA findings, quantification attempts, anatomical data and
the impact of ICGA on postoperative anastomotic complications, were collected
by 2 independent researchers. The quality of the included articles was assessed
based on the Methodological Index for Non-Randomized Studies. The 19
included studies presented data on 1192 esophagectomy patients, in 758 patients
ICGA was used perioperative to guide esophageal reconstruction.
RESULTS
The 19 included studies for qualitative analyses all described ICGA as a safe and
easy method to evaluate gastric graft perfusion. AL occurred in 13.8% of the
entire cohort, 10% in the ICG guided group and 20.6% in the control group (P <
0.001). When poorly perfused cases are excluded from the analyses, the difference
in AL was even larger (AL well-perfused group 6.3% vs control group 20.5%, P <
0.001). The AL rate in the group with an altered surgical plan based on the ICG
image was 6.5%, similar to the well perfused group (6.3%) and significantly less
than the poorly perfused group (47.8%) (P < 0.001), suggesting that the technique
is able to identify and alter a potential bad outcome.
CONCLUSION
ICGA is a safe, feasible and promising method for perfusion assessment. The
lower AL rate in the well perfused group suggest that a good fluorescent signal
predicts a good outcome.
Key words: Indocyanine green; Angiography; Fluorescence; Esophagectomy;
Anastomotic leak; Near-infrared spectroscopy; Esophageal neoplasms; Esophageal cancer
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: Esophagectomy is a surgery known for its complexity and potentially high
morbidity associated with postoperative anastomotic leakage (AL). This review
evaluates Indocyanine green fluorescence angiography (ICGA) as a safe, feasible and
promising method to assess graft perfusion during esophageal reconstructive surgery.
We discuss the safety, the methodology and the effectiveness of ICGA and its potential
to reduce AL rate.
Citation: Van Daele E, Van Nieuwenhove Y, Ceelen W, Vanhove C, Braeckman BP, Hoorens
A, Van Limmen J, Varin O, Van de Putte D, Willaert W, Pattyn P. Near-infrared fluorescence





The incidence of esophageal adenocarcinoma has rapidly increased over the past two
decades[1]. For locally and locally advanced esophageal cancer (EC) patients, surgical
resection remains the cornerstone of their treatment. The stomach is most commonly
used to restore continuity of the upper gastrointestinal tract after an oesophagus
resection. However, these esophago-gastric anastomotic sites (AS) are fragile and
prone to complications as leakage,  fistulas,  bleeding,  and stricture.  Anastomotic
leakage (AL) remains the main cause of postoperative morbidity and mortality in
digestive reconstructive surgery. After an esophagectomy leakage incidence ranges
from 5% to 20%[2-6]. Literature reports leak-associated mortality rates from 18% to 40%
compared to an overall  in-hospital  mortality of  4% to 6%[2,7,8].  Age,  male gender,
smoking,  alcohol  abuse,  American  Society  of  Anaesthesiologists  score,  obesity,
emergency surgery, prolonged operative time, intraoperative blood loss, diabetes,
renal failure, use of corticosteroids and cardiovascular disease are identified as risk
factors for AL, potentially through impaired perfusion of the gastric graft[2,4-6,8-11].
Graft  perfusion  is  considered  to  be  an  important  predictor  for  anastomotic
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integrity. Currently, tissue perfusion is assessed using subjective parameters such as
tissue colour and vessel pulsations. However, these parameters are known to be of
limited predictive value, emphasizing the clear need for a safe, reproducible, and non-
invasive method to objectively assess tissue viability and graft perfusion.
Several methods have been tested for intraoperative evaluation of graft perfusion,
such  as  laser  speckle  contrast  imaging,  gastric  tonometry,  Doppler  flowmetry,
spectroscopy and angiography[12-15]. None of them have been widely accepted due to
limited feasibility, reproducibility issues or costs. Near infrared fluorescent (NIRF)
imaging requires a fluorescence-imaging agent that can be excited in the tissue at near
infrared (NIR) wavelengths by penetrating NIR light. A 2D image of tissue deposition
of the NIRF imaging agent can be created based on the fluorescence generated by the
excited NIRF agent and captured by adapted cameras. Indocyanine green (ICG) is a
clinically approved NIRF agent to determine cardiac output, hepatic function, and
ophthalmic angiography. ICG is known for its absorption maximum around 760-780
nm, its immediate binding with plasma proteins resulting in a confinement to the
vascular compartment, its low toxicity and its rapid and exclusive biliary excretion. Its
excellent safety record has added to the rapid food and drug administration approval
for  clinical  use  in  1956[16].  Recent  developments  of  new hardware  have  made  it
possible to perform Indocyanine green fluorescence angiography (ICGA) not only in
open, but also during minimally invasive surgery, resulting in a general interest of the
surgical community in this technique as a method to visualize anastomotic perfusion
and its potential  to reduce AL risk.  At present ICGA is not a standard guideline
during esophageal surgery because of the lack of prospective randomized studies, but
many expert centers already incorporate perioperative ICGA as a routine step during
esophageal reconstruction.
This  study  aimed  to  systematically  review  the  literature  on  feasibility  and
effectiveness of ICGA use as a method to evaluate graft perfusion and as a predictor
of  AL after  esophageal  reconstructive surgery.  Additionally,  current methods to
quantify ICGA in esophageal reconstructive surgery were reviewed.
MATERIALS AND METHODS
This study was designed according to the PRISMA guidelines and registered in the
PROSPERO 2018 database  (www.crd.york.ac.uk).  The registration identification
number is CRD42018100503.
Eligibility criteria
Only  English  written  studies  on  human  subjects  were  included  in  the  study.
Publications were excluded if they reported on a primary intervention other than
ICGA or when they did not present original patient data. Conference abstracts, case
reports, technical notes, letters, comments, duplications and animal studies were also
excluded. Study selection was based on the population, intervention, comparison,
outcome principle.  The population was defined as  patients  undergoing esopha-
gectomy for EC with gastric graft reconstruction. The intervention is ICGA for the
intraoperative assessment of gastric graft perfusion. Comparison was done with non
ICGA guided esophagectomy patients if a control group was present. The primary
objective  was  feasibility  of  ICGA  as  a  method  to  evaluate  graft  perfusion.  The
secondary objective was the effect of ICGA on alterations of the surgical plan and its
ability to predict and avoid AL. The final objective was to evaluate current attempts to
quantify ICGA in esophageal reconstructive surgery.
Search strategy
PubMed and EMBASE were  independently  searched by 2  reviewers  for  studies
presenting data on intraoperative ICGA gastric graft perfusion assessment during
esophago-gastric reconstruction after esophagectomy. The search was last updated in
October  2018.  The  following  MeSH  terms  were  used  in  the  PubMed  database
searches: “Esophagectomy”[MeSH] OR “Esophagus surgery” OR “Esophagus cancer”
OR  “Esophagus”  OR  “Esophag*”  AND  “Indocyanine  green”[MeSH]  OR
“angiography”[MeSH] OR “ICG” OR “graft perfusion” OR “near infrared imaging”
OR “near infrared fluorescence”.  Same Emtree terms were used in the EMBASE
database. Titles and abstracts were screened for eligibility. After reading full text
articles, duplicates were extracted, and references were screened to identify additional
articles.  Consensus  was  reached  by  the  2  reviewers  after  re-review  in  case  of
discordances in study selection.
Methodological quality appraisal
The quality of the included articles was assessed based on the Methodological Index
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for Non-Randomized Studies (MINORS), a validated quality assessment system with
8 items for non-comparative and 12 items for comparative studies. The maximum
score for non-comparative studies is 16 and 24 for the comparative studies[17].
Data extraction, management and synthesis
Study design, patients’ demographic data, intervention related data and outcomes
were extracted from the included studies. Study data were collected by 2 independent
researchers in a standard Excel™ data collection sheet which was used to calculate
descriptive  statistics  for  all  measured  parameters.  Continuous  and  categorical
variables were summarized as means with standard deviation, and/or median with
IQR or ranges. Data were analyzed using SPSS version 22 for windows (SPSS Inc.,
Chicago, IL). Statistical analysis using a fisher exact- test was performed to compare




The initial database searches resulted in 251 eligible abstracts and citations and 3
additional  records  were  found  through  reference  checking.  After  adjusting  for
duplicates and screening of the abstracts,  23 full  text articles remained and were
reviewed in detail, resulting in the exclusion of another 4[18-40]. Finally, 19 papers met
the inclusion criteria for qualitative analysis[18-23,25-28,30,33-40]. Six articles could be used for
separate quantitative analyses as they contained data of a comparison group[25,26,35-38].
The PRISMA flowchart of the search is shown in Figure 1.
Study and population characteristics
Study characteristics of the 19 included studies and demographic data of the included
patients  are  described in  Table  1.  Ten studies  were  feasibility  studies,  6  studies
compared the ICGA study cohort to a historical  non ICGA cohort,  and 3 studies
evaluated outcome of patients with adequately versus poorly ICGA perfused AS. In
total, 1192 (82% male) esophagectomy patients were analyzed. In 758 patients, ICGA
was used perioperative to guide esophageal reconstruction compared to 434 patients
was the anastomotic site was determined based on clinical judgment and/or Doppler
ultrasound.
Methodological quality of the studies
All included studies were feasibility-or non-randomized controlled studies and the
risk of bias within the studies was, therefore, analyzed according to the MINORS
methodological  index[17].  The  score  varied  from  4  to  13  (median  6)  for  non-
comparative studies (max score 16) and from 6 to 18 (median 16) for the comparative
studies (max score 24).  Most studies had a clear aim and appropriate endpoints,
however the follow-up period and loss to follow-up were rarely mentioned. None had
unbiased endpoint assessment or power calculations.
ICGA feasibility and safety analysis
All studies reported ICGA to be feasible and easy. Many different imaging systems
were described both for open and minimally invasive use, and different dosages of
ICG  were  used  (Table  1).  Nevertheless,  all  authors  were  able  to  obtain  good
intraoperative NIRF images and no equipment malfunction was mentioned.  The
timeframe during which GT perfusion was visualized varied from a few seconds to a
few minutes after injection of the dye. Shimada et al[40] described good visualization of
the GT vasculature at the greater curvature after 1 min, the mucosal arterial network
was nicely visible after 2 min. Kumagai et al[39] reported a median time of 27.9 s. (14.6-
141.7) from initial fluorescence of the root of the right gastroepiploic artery to the tip
of the GT in his first cohort and 35.3 s (13-204) in the second cohort, comparable to
Sarkari’s  median  37.5  s  (20-105)[21,25,39].  Karampiris  et  al[36]  reported  a  mean total
duration of the ICGA of 173 s (± 74),  leading him to conclude that ICGA did not
significantly  increase  operating time (P  =  0.8).  All  authors  reported ICGA to  be
uneventful  and  well  tolerated.  None  of  the  authors  reported  adverse
reactions[18-23,25-28,30,33-40]. Murawa et al[19] was the only author who reported a transient
but  uncomplicated drop in oxygen saturation to  90% immediately after  admini-
stration of the dye in his study group.
Quantification and validation
Five studies reported an attempt to objective quantification of the ICGA signal based
on time and/or intensity of the fluorescence[21,27,30,37,39]. Kumagai et al[21] first reported a
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Figure 1
Figure 1  PRISMA flowchart of the search. ICGA: Indocyanine green fluorescence angiography; GT: Gastric tube.
significantly longer time registration from initial fluorescence at the root of right
gastroepiploic artery until perfusion of the tip in both AL patients. Yukaya’s study
objectively assessed the gastric conduit vascularization based on inflow and outflow
delays in perfusion detected on 2 points of the gastric conduit. Patterns of NIRF were
categorized into three types of blood flow: Normal flow, delayed inflow and delayed
outflow. The study could not show significant differences in AL, but the authors did
provide a quantitative evaluation method of the NIRF image based on time intensity
curves[27]. Koyanagi et al[30] quantified flow speed of NIRF in the gastric wall. Based on
the length of the GT, anatomical connection between the right and left gastroepiploic
artery and the speed of the fluorescence, 2 groups of patients were identified. A group
with simultaneous NIRF in the gastric conduit wall  and in the greater curvature
vessels beyond the watershed region and a delayed group with obviously slower
NIRF in the gastric conduit wall  compared to the greater curvature vessels.  Risk
assessment identified flow speed of the NIRF as a predictor of AL (P  = 0.002).  A
receiver operating characteristics curve determined a cut-off value of 1.76 cm/s or less
as a significant independent AL predictor (P = 0.004)[30]. Noma et al[37] and Kumagai et
al[39]  published  a  more  simplified  quantification  method  based  on  time  of  GT
perfusion. Noma’s 30 s rule included an ICGA 20 s-and 30 s demarcation line on the
GT. After pulling up the stomach all cervical anastomoses were made proximal from
the  30  s  border[37].  Recently,  Kumagai  et  al[39]  published  the  90  s  rule  where  all
anastomoses  were  made  in  areas  where  less  than  90  s  were  needed  for  NIRF
enhancement.
Influence of intraoperative ICGA on the surgical plan
The  intraoperative  consequences  of  gastric  tube  (GT)  perfusion  assessment  are
summarized in Table 2. Within the entire study cohort, perioperative ICGA resulted
in a change of the surgical plan in 93 patients (12.4% of the study group). Different
surgical approaches were described to secure sufficient perfusion to the anastomotic
site  for  patients  with  an  impaired  perfusion  on  ICGA.  Four  authors  mentioned
relocation of the anastomosis with resection of the poorly perfused tip if the GT was
sufficient in length[33,36,38,39]. In three studies, authors chose to switch from an end-to-
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Neoadjuvant treatment: CT: Chemotherapy, RT: Radiotherapy, CRT: Chemo radiation; Fluorescent imaging system: PDE: Photodynamic Eye; Hamamatsu
Photonics K.K, Hamamatsu, Japan; HEMS: Hyper Eye Medical System; Mizuho Ikakogyo Co., Tokyo, Japan; ICView: Pulsion Medical Systems, Munich,
Germany; SPY: SPY Imaging System, Novadaq Industries Inc., Toronto, Canada; FireFly: Firefly Fluorescence Imaging Scope, Intuitive Surgical, Sunnyvale,
Canada; IMAGE1: IMAGE1 STORZ professional image enhancement system; PinPoint: PinPoint system, Novadaq, Ontario, Canada; ICGA: Indocyanine
green fluorescence angiography;  AL:  Anastomotic  leakage;  GT:  Gastric  tube;  MINORS:  Methodological  Index for  Non-Randomized Studies;  AS:
Anastomotic sites; RAMIE: Robotic assisted minimally invasive esophagectomy.
side anastomosis to an end-to-end anastomosis to reduce the necessary GT length
needed for a cervical anastomosis[19,34,35]. Finally, four authors made additional arterial
or venous anastomosis between the GT vasculature and carotid artery or jugular vein
to  increase  arterial  perfusion  or  venous  drainage  of  the  cervical  anastomosis,  a
technique also known as supercharge or super drainage[34,35,37,40]. Both Ohi et al[35] and
Noma et al[37] described a step-up surgical protocol for a well perfused anastomotic
site. Changing the surgical plan seemed very efficient, as AL after an altered surgical
plan occurred in 6.5% of patients, comparable to the 6.3% AL rate in the well perfused
cohort and significantly less common than the 20.5% AL rate in the non ICG cohort (P
< 0.001).
The effect of ICGA guided surgery on AL
In 1186 patients, a primary esophagogastric anastomosis was made. The 6 patients, in
whom Zehetner et al[28] decided to perform an ischemic conditioning with delayed
anastomosis  were excluded from further analyses.  In the entire  cohort,  13.8% of
patients suffered from AL, 9.9% in the ICGA guided group and 20.5% in the control
group (P < 0.001). Within the group of ICGA guided esophagogastric anastomosis,
592 had a good ICGA perfusion,  but  still  resulted in 6.3% AL rate.  Ninety-three
patients  had  a  low  perfusion  at  the  tip  of  the  GT,  for  which  different  types  of
corrections were performed resulting in an adequate tip perfusion and an AL rate of
6.5%, comparable to the AL rate of the well perfused cohort and significantly lower
than the 47.8% AL rate  in the poorly perfused group (P  <  0.001)  (Figure 2).  The
difference in AL rate is even clearer considering only the cohort with a control group
(P < 0.001) (Figure 3).
DISCUSSION
Surgeons lack the ability to predict AL based simply on gross inspection of tissue
viability, emphasizing the need for a safe, reproducible, and non-invasive method for
perfusion assessment, especially in esophageal reconstructive surgery. We aimed to
review the literature on the feasibility and effectiveness of ICGA as a method to
evaluate graft perfusion and as a predictor of AL after esophagectomy. In addition,
we evaluated published attempts to quantify ICGA based imaging data in esophageal
surgery.
Based on the 1192 included patients, we conclude that ICGA is an easy, safe and
feasible  method for  GT perfusion  assessment  during  esophageal  reconstructive
surgery. There are no reported technical failures of the different ICGA platforms, nor
reports of adverse events, except for an uneventful and transient drop in oxygen
saturation immediately after admission of the ICG, suggesting that this is a ready to
use  method  with  very  limited  risk  and  learning  curve.  The  transient  drop  in
percutaneous oxygen saturation measurement via pulse oximetry is a misreading due
to the interference of the dye’s absorption spectra used by optical-technology-based
monitors who interfere with the oximetry readings.
The time required for assessment of GT perfusion varied from a few seconds to a
few minutes after injection of the dye, which does not significantly affect operating
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Table 2  Influence of Indocyanine green fluorescence angiography on intraoperative decisions and on anastomotic leakage
Ref. Entire cohort n =1186
ICGA study group n =
752 Non ICGA n = 434
ICGA good perfused
AS, n = 592
ICGA good perfused
altered AS, n = 93
ICGA poor perfused AS,
n = 67
Shimada et al[40] 3/36 2/31 1/5 Superdrainage - -
Kubota et al[18] 0/4 0/4 - - -
Murawa et al[19] 1/15 1/11 0/4 End-to-end - -
Pacheco et al[20] 2/11 1/10 - 1/1 -
Kumagai et al[21] 2/20 2/20 - - -
Rino et al[22] 5/33 5/33 - - -
Sarkaria et al[23] 2/30 2/30 - - -
Hodari et al[25] 3/54 0/39 - - 3/15
Campbell et al[26] 12/90 0/21 - - 12/69
Yukaya et al[27] 9/27 9/27 - - -
Zehetner et al[28] 24/144 2/95 - 22/49 -
Koyonagi et al[30] 7/40 0/25 - 7/15 -
Schlottmann et al[33] 0/5 0/3 0/2 resection - -
Kitagawa et al[29,34] 7/72 3/41 ICG-LMM 0/5 ICG-LMM - -
4/26 ICG - 0/4 End-to-end
- 0/1 Superdrainage





Karampiris et al[36] 13/90 0/7 1/26 Resection 2/2 10/55
Noma et al[37] 60/285 6/70 0/1 Supercharge/drain - 54/214
Dalton et al[38] 3/40 0/14 2/6 Resection - 1/20
Kumagai et al[39] 1/70 0/35 1/35 Resection - -
ICGA: Indocyanine green fluorescence angiography.
time. Different teams used different dosages of ICG varying from 2.5 mg to 25 mg, but
none reported serious adverse events, and all described good visualization. Diana[41-43]
performed an optimal dosage study in a pig model resulting in a dose of 0.5 mg/kg as
optimal dose for a reliable fluorescence that could be converted into a time intensity
curve with their VR RENDER perfusion software. At present optimal doses of 0.2-0.5
mg/kg are mentioned in literature, mainly based on the study of Diana, nevertheless
many of the included studies have shown that GT perfusion could be visualized using
a much lower (and potentially less toxic) dose. A recent practical guide for ICGA
guided abdominal surgery also concluded on a bolus dose of 2.5 mg as optimal dose
for  simple  visualization  of  both  esophagogastric  and  colorectal  anastomotic
perfusion[44].
Only a few authors have attempted to quantify the method, usually in colorectal
surgery, but comparison with a golden standard method is rarely reported. The only
quantitative attempt to validate ICGA as a reliable perfusion assessment tool was
performed by Diana et al[41-43], who showed that the time intensity curves of the NIRF
images correlate with hypo-perfusion and tissue ischemia in an experimental pig
model of small bowel ischemia[41-43]. Only five studies reported an attempt to quantify
the  ICGA  signal  during  esophageal  surgery,  based  on  the  speed  of  fluorescent
coloring of the GT after injection of the dye[21,27,30,37,39]. Koyanagi et al[30] added the length
of the GT and anatomical connection between the right and left gastroepiploic artery.
A ROC curve analysis determined a cut-off value of 1.76 cm/s or less as a significant
independent AL predictor (P = 0.004)[30]. Yukaya’s study assessed perfusion based on
inflow and outflow delays detected on 2 points of the gastric conduit. That study
could not show significant differences in AL between flow types, but the authors did
provide the first and only quantitative evaluation method based on time intensity
curves in esophageal surgery[27].
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Figure 2
Figure 2  Anastomotic leakage rates of the entire cohort. ICGA: Indocyanine green fluorescence angiography; AL:
Anastomotic leakage; AS: Anastomotic sites.
AL occurred in 13.8% of the entire cohort, which is in line within the normal range
according to the literature. At present, there are no randomized trials to support the
alteration of the surgical plan based on the ICGA images. Nevertheless, the most
promising aspect of ICGA perfusion assessment is probably its ability to change the
surgical plan. In this review population of 1186 patients, the surgeon chose to change
the surgical plan to increase the blood flow to the anastomotic site, in 93 cases. The
chosen technique varied with surgeon preference and location of the anastomosis. The
AL rate in this altered anastomotic site group was 6.5%, similar to the well perfused
group (6.3%) and significantly less than the poorly perfused group (47.8%) (P < 0.001).
These results suggest that the technique is able to predict and remedy a potentially
worse outcome, but randomized trials  are needed to confirm these retrospective
results.
This review is based on 19 studies with considerable inter-study heterogeneity,
making comparison between studies difficult. Methods of ICGA interpretation and
surgical  consequences  varied  among the  different  study cohorts.  Moreover,  the
included manuscripts  are  mainly prospective feasibility  studies  or  retrospective
analyses of low-grade evidence and with relatively low MINOR scores. The studies
with a control group were all retrospective comparisons to historical control groups.
Most  studies  had  incomplete  or  unmentioned  follow-up  periods  and  lacked
prospective sample size calculations.
The present review suggests that ICGA is a safe, feasible and promising method to
assess graft perfusion that might help reducing AL. At present optimal doses of 0.2-
0.5 mg/kg are mentioned in literature but based on this review a bolus dose of 2.5 mg
is  a  sufficient  optimal  dose  for  visualization  of  esophagogastric  anastomotic
perfusion.
A few authors have attempted to quantify the method, but rarely in oesophageal
surgery and without comparison with a golden standard method, stressing the need
for objective quantification of the ICGA with validated cutoff levels for sufficient graft
perfusion in esophageal surgery. No studies mentioned validation of the method.
Objective,  in  depth  assessment  of  tissue  perfusion  using  NIRF  imaging  during
creation of the esophagogastric anastomosis in EC surgery is lacking. Therefore, we
propose a clinical study that uses NIRF dynamic images to calculate physiologically
relevant  parameters  (blood flow,  blood volume,  vascular  leakage)  and generate
pseudocolor  coded  parametric  maps  using  advanced  curve  analysis  and
compartmental modelling (adiabatic approximation to tissue homogeneity model,
AATH)[45,46].  In addition,  this  study would be the first  to validate imaging-based
perfusion assessment of the stomach graft using tissue, serum, and cellular hallmarks
of hypo-perfusion and hypoxia during esophagectomy[47]. The study is registered in
Clinicaltrials.gov as NCT03587532 and is currently recruiting.
The differences in AL rate between the well perfused and poor perfused AS clearly
suggest that a good fluorescent signal is a predictor of good outcome. The AL rate in
the group with an altered surgical plan based on the ICG image was similar to the
well perfused group and significantly less than the poorly perfused group, suggesting
that  the  technique  is  able  to  predict  and  remedy  a  potentially  worse  outcome.
Reducing AL after oesophageal reconstruction is an ongoing goal of the oesophageal
surgical community, this easy and safe new technique of perioperative perfusion
assessment  has  the potential  to  reduce AL rate  and its  associated mortality,  but
randomized trials  are needed to confirm these retrospective results.  However,  a
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Figure 3
Figure 3  Anastomotic leakage rates of the cohort with a historical control group. ICGA: Indocyanine green
fluorescence angiography; AL: Anastomotic leakage; AS: Anastomotic sites.
prospective randomized study can only compare ICGA guided surgery versus non
ICGA guided surgery and that implies a large sample size demanding a multicentre
study. Comparing in a randomized fashion ICGA good perfused anastomoses versus
ICGA  poor  perfused  anastomosis  would  be  scientifically  perfect  but  ethically




After an esophagectomy, the stomach is most commonly used to restore continuity of the upper
gastrointestinal tract. These esophago-gastric anastomoses are prone to serious complications
such as leakage associated with high morbidity and mortality. The main cause of anastomotic
leakage (AL) is tissue hypoxia, which results from impaired perfusion of the pedicled gastric
tube (GT). Clinical judgment is unreliable in determining GT perfusion.
Research motivation
An objective, validated, and reproducible method to evaluate tissue perfusion at the anastomotic
site  is  urgently  needed.  Based  on  the  current  literature  we  believe  Indocyanine  green
fluorescence angiography (ICGA) is an easy and cheap assessment tool for GT perfusion, that
might predict and therefore alter a potentially bad outcome.
Research objectives
This study aimed to systematically review the literature on feasibility and effectiveness of ICGA
use  as  a  method  to  evaluate  graft  perfusion  and  as  a  predictor  of  AL  after  esophageal
reconstructive  surgery.  Additionally,  current  methods  to  quantify  ICGA  in  esophageal
reconstructive surgery were reviewed.
Research methods
This study was designed according to the PRISMA guidelines and registered in the PROSPERO
database.  Pubmed  and  Embase  were  independently  searched  by  2  reviewers  for  studies
presenting data on intraoperative ICGA GT perfusion assessment during esophago-gastric
reconstruction after  esophagectomy.  Relevant  outcomes such as  feasibility,  complications,
intraoperative surgical changes based on ICGA findings, quantification attempts, anatomical
data and the impact of ICGA on postoperative anastomotic complications, were collected by 2
independent researchers. The quality of the included articles was assessed based on the MINORS
criteria. The 19 included studies presented data on 1192 esophagectomy patients, in 758 patients
ICGA was used perioperative to guide esophageal reconstruction.
Research results
The 19 included studies for qualitative analyses all  described ICGA as a safe and easy. AL
occurred in 13.8% of the entire cohort, 10% in the ICG guided group and 20.6% in the control
group (P < 0.001). When poorly perfused cases are excluded from the analyses, the difference in
AL was even larger (AL well-perfused group 6.3% vs control group 20.5%, P < 0.001). The AL
rate in the group with an altered surgical plan based on the ICG image was 6.5%, similar to the
well perfused group (6.3%) and significantly less than the poorly perfused group (47.8%) (P <
0.001), suggesting that the technique is able to identify and alter a potential bad outcome.
Research conclusions
ICGA is a safe, feasible and promising method for perfusion assessment. Based on this review a
bolus dose of 2.5 mg is a sufficient optimal dose for visualization of esophagogastric anastomotic
perfusion. The differences in AL rate between the well perfused and poor perfused AS clearly
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suggest that a good fluorescent signal is a predictor of good outcome. The AL rate in the group
with an altered surgical plan based on the ICG image was similar to the well perfused group and
significantly less than the poorly perfused group, suggesting that the technique is able to predict
and remedy a potentially worse outcome.
Research perspectives
A few authors have attempted to quantify the method, but rarely in oesophageal surgery and
without  comparison  with  a  golden  standard  method,  stressing  the  need  for  objective
quantification  of  the  ICGA  with  validated  cutoff  levels  for  sufficient  graft  perfusion  in
esophageal surgery. No studies mentioned validation of the method. Therefore, we propose a
clinical study that validates imaging-based perfusion assessment of the stomach graft using
tissue, serum, and cellular hallmarks of hypo-perfusion and hypoxia during esophagectomy. The
study is registered in Clinicaltrials.gov as NCT03587532 and is currently recruiting. This easy
and safe new technique of perioperative perfusion assessment has the potential to reduce AL
rate and its associated mortality, but randomized trials are needed to confirm these retrospective
results. At present, there are no ongoing randomized trials listed on clinical trial.gov. Potentially
because a prospective randomized study comparing ICGA guided surgery versus non ICGA
guided surgery implies a large sample size demanding a large multicentre study.
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